Heart, Lung and Circulation
Volume 18, Issue 3 , Pages 171-180, June 2009

Bone Marrow-derived Stem/Progenitor Cells: Their Use in Clinical Studies for the Treatment of Myocardial Infarction

  • Gabriel P. Lasala, MD, FACC
    • ,
  • José J. Minguell, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author at: 101 E. Fairway Drive, Suite 514, Covington, LA 70433, USA. Tel.: +1 985 867 4860; fax: +1 985 867 8259.

TCA Cellular Therapy, LLC, Covington, LA 70433, USA

Received 7 July 2008; received in revised form 9 September 2008; accepted 10 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1443-9506(08)00874-3

doi:10.1016/j.hlc.2008.09.007

Heart, Lung and Circulation
Volume 18, Issue 3 , Pages 171-180, June 2009

Article Tools